Telepathology Cancer Services Market Research Report – Segmented By Technology (Whole-Slide Imaging Systems, Artificial Intelligence and Machine Learning, Cloud-Based Solutions, and Others); By Application (Diagnosis and Consultation, Research, Education, and Others); By End User (Hospitals, Diagnostic Centers and Pathological Clinics, Research Institutes, and Others); and Region- Size, Share, Growth Analysis | Forecast (2023 – 2030)

Telepathology Cancer Services Market Size (2023 – 2030)

The global telepathology cancer services market was valued at USD 70.99 Million and is projected to reach a market size of USD 113.99 Million by the end of 2030. Over the forecast period of 2023–2030, the market is projected to grow at a CAGR of 7%.

Doctors can practice pathology remotely via telepathology, a kind of telemedicine. Using communication networks entails sending microscopic and/or macroscopic pictures. This market had a limited presence in the past due to unstable networks, difficult access, and underdeveloped economies. However, during the early 2000s, this method started to gain recognition. Countries were rapidly adopting digital technologies and coming up with advancements. Besides, clinical acceptance was being gained. In the future, with the rising adoption of digitalization and economic stability, this market is set to see a good expansion.

Key Market Insights:

The worldwide digital pathology industry amounted to five billion dollars in sales in 2019. The market research firm Next Move Strategy Consulting projects that by 2030, this amount will have increased to over 17 billion USD.

Approximately 7.6 billion US dollars were funded for cancer by the NIH in fiscal year 2022.

Global spending on cancer was estimated to be 193 billion dollars in 2022. Costs six years prior were 90 billion dollars, in contrast.

Eighty-two percent of health insurers in Asia Pacific stated in 2021 that their members may access telehealth and telemedicine services via third-party vendors or partners. However, 12% of insurers globally stated that they did not provide telemedicine or telehealth services to their subscribers. Measures are being taken to make sure everybody has equal access to technology. Awareness programs and funds from the government are being implemented.

Telepathology Cancer Services Market Drivers:

The increased need for remote services is paving the way for the market to succeed.

As per Statista, an increasing number of new cancer cases are being diagnosed worldwide as the population ages, which is leading to an increase in the annual death toll. Globally, cancer was the cause of around 10 million deaths in 2020; by 2040, that figure is predicted to rise to over 16 million. This rising prevalence has increased the workload on medical professionals and staff providing services. Besides, care should be taken about hygiene facilities to prevent any sort of contamination. Remote monitoring becomes an added advantage to eradicate these issues. Patients can access doctors virtually, thereby aiding in faster diagnosis. This is a huge benefit to areas where there are no physical clinics present. Additionally, people can take consultations globally. Moreover, cost reduction is achieved by cutting transportation and other miscellaneous expenses. Accurate diagnosis and treatment are ensured, thereby contributing to the rising adoption.

Technological advancements are facilitating the market's expansion.

Healthcare systems are being integrated with advanced technologies to improve accuracy and precision. Artificial intelligence has been a boon for the market. AI solutions are helping in better tumor detection, pattern identification, and quantitative analysis. Cloud-based solutions are being employed for data security. Digital pathology is being improved in terms of analysis, collection, and storage. Internet connectivity and telecommunications are being upgraded for better audio and video quality. Remote robotic microscopy is boosting the growth of accurate diagnosis through real-time examination. Investments from various organizations and other business tycoons are helping to elevate existing technologies. Furthermore, R&D activities are being undertaken to broaden human understanding.

Telepathology Cancer Services Market Restraints and Challenges:

Networks, costs, data privacy, training, and standardization are the main concerns that the market is currently experiencing.

One of the biggest hindrances the market is currently facing is limited access in remote and underdeveloped areas. Wi-Fi and other resources are the main issues that are difficult to accommodate. This can create difficulties for patients. Secondly, the initial set-up expenses can take a toll. This is challenging for smaller clinics and hospitals. Additionally, maintenance charges also add up. Thirdly, the security of data is often questioned. Leakage of sensitive information can cause significant losses for the individual and the end user. Moreover, accurate training of professionals can be time-consuming. Many times, the older generation might not be fully aware of the usage. Few others can be hesitant to embrace the new change. Furthermore, the quality of treatment can cause hurdles. Since everything happens through online mode, it is extremely important to maintain image quality, correctness, and reliability.

Telepathology Cancer Services Market Opportunities:

The deployment of cost-effective solutions has been providing the market with an ample number of possibilities. This ensures easier availability and accessibility for smaller clinics. Secondly, education and training about these services are being prioritized. This allows pathologists, physicians, and other licensed faculty to know about the methods and procedures. Thirdly, enhanced remote consultations are being achieved through global operations, expansions, and collaborations. This helps in the creation of better public health. Furthermore, Stanford University researchers claim to be working on a wearable gadget that can gauge cancerous growth. The FAST gadget is equipped with integrated sensors that are intended to monitor tumor development and shrinking.

TELEPATHOLOGY CANCER SERVICES MARKET REPORT COVERAGE:

Telepathology Cancer Services Market Segmentation: By Technology

• Whole-Slide Imaging Systems

• Artificial Intelligence and Machine Learning

• Cloud-Based Solutions

• Others

Based on technology AI and ML is both the largest and fastest-growing segment. AI has the high accuracy needed to diagnose cancer. It can precisely identify lymph node metastases and assign grades, such as the Gleason score for prostate cancer. The use of AI to forecast gene mutations via histologic analysis is also being investigated. By examining tissue sample slides, researchers were able to diagnose two prevalent kinds of lung cancer with a 97% accuracy rate using machine learning (ML). The system examined images of cancerous cells and identified genetic alterations linked to the illness.

Telepathology Cancer Services Market Segmentation: By Application

• Diagnosis and Consultation

• Research

• Education

• Others

Diagnosis and consultation are the largest applications in this market. Over the years, changes in lifestyle, hectic schedules, increased junk food consumption, and other environmental factors have contributed to the increasing incidence of diseases. Cancer has become a very common disease, affecting a lot of individuals. This has boosted the growth of this segment to provide superior, efficient, and high-quality healthcare services. This segment has seen good growth after the pandemic owing to digitalization. During the forecast period, a tremendous growth rate is expected. Research is considered to be the fastest-growing. This is because a greater number of scientists and researchers are interested in pursuing a career in this field. Opportunities like grants, research funding, and awards are being provided by governmental agencies. Since cancer has no one particular cure, the chances of relapsing can never be eliminated. This has further piqued the curiosity of universities, research institutes, and other labs to widen human knowledge.

Telepathology Cancer Services Market Segmentation: By End User

• Hospitals

• Diagnostic Centers and Pathological Clinics

• Research Institutes

• Others

Based on end users, hospitals are the largest segment in the market. This is because of infrastructure and resource availability, top-notch treatments, easy access, the presence of skilled expertise, demand, technological advancements, and collaborations. Diagnostic centers and pathological clinics are the fastest-growing owing to rising demand, investments, applications, cost-effectiveness, and an increasing number of centers.

Telepathology Cancer Services Market Segmentation: Regional Analysis

• North America

• Asia-Pacific

• Europe

• South America

• Middle East and Africa

North America is the largest growing region with countries like the United States and Canada at the forefront. The progress in this region is due to technological advancements, the presence of key companies, infrastructure availability, economic strength, internet connections, research activities, the prevalence of cancer, and awareness. North America holds a rough share of around 37% in this market. However, Asia-Pacific is the fastest-growing region, with an approximate share of 22%. Countries like China, India, and Japan have shown great improvements. Factors like urbanization, rising middle class, increasing disposable income, collaborations, emerging companies, accessibility, R&D activities, technological improvements, economic stability, awareness, and governmental involvement, funds, and education programs. Europe, with countries like Germany, the United Kingdom, Italy, and the Netherlands is among the leading countries. This is because of strides in the AI field, telemedicine, and advanced healthcare infrastructure.

COVID-19 Impact Analysis on the Global Telepathology Cancer Services Market:

The outbreak of the virus had a positive impact on the market. Lockdowns, restricted movement, and social isolation were all part of the new normal. Hospitals were flooded with patients affected by the coronavirus. Many regions faced a depletion of resources like beds, ventilators, oxygen cylinders, etc. The media instilled mass fear. There was a lot of jargon and misinformation being spread. People were not ready to visit care centers. Remote services like telemedicine saw good adoption. The pandemic caused a trend towards digitalization. Individuals started to trust virtual services. Initially, it was difficult. However, people started to accept the new norm very soon. Besides, much governmental funding and investment were shifted towards healthcare applications. Telepathological services were among them. Training and awareness programs were being supported. As per Statista, a survey carried out between March and May 2020 revealed a remarkable 700 percent increase in the share of tele-ophthalmology. Post-pandemic, the shift is being embraced.

Latest Trends/ Developments:

The companies in this market are motivated to achieve a higher market share by implementing different strategies, such as acquisitions, partnerships, and investments. Companies are also spending heavily to improve existing technologies while maintaining competitive pricing.

Blockchain integration enables the secure transmission of data. In a cryptographic chain, every new block is connected to every previous block in a way that makes tampering almost impossible. A consensus process confirms and verifies each transaction inside the blocks, guaranteeing that each is accurate and truthful. This rejects unauthorized entry. A greater number of organizations are integrating these services. Additionally, this can create consumer trust.

Key Players:

1. Philips Healthcare

2. Leica Biosystems

3. Roche Diagnostics

4. OptraSCAN

5. Hamamatsu Photonics

6. Apollo Enterprise Imaging Corp

7. Visiopharm

8. Mikroscan Technologies

9. DigiPath Solutions

10. Inspirata

In November 2021, Dr. Lal PathLabs and Ibex Medical Analytics collaborated to deploy the first AI-powered cancer diagnostic platform in India that aids pathologists during routine cancer diagnosis and expedites the quality and speed of cancer testing.

In April 2021, the AI-powered cancer diagnostics platform Galen from Ibex Medical Analytics was integrated with the Philips IntelliSite Pathology Solution from Royal Philips. The agreement aimed to provide objective, repeatable results, boost diagnostic confidence, and allow the productivity and efficiency gains necessary to meet the growing demand for pathology-based diagnostics.

In June 2020, Philips and Proscia collaborated to advance the open digital pathology ecosystem. By using best-of-breed techniques for image storage, computational pathology, and scanning, collaboration aimed to speed the implementation of digital technology.